Professor Mario Campone, MD PhD
Professor Mario Campone is currently an in-hospital practitioner and oncology specialist at l’Institut de Cancérologie de l'Ouest.
He holds a Doctorate in Medical Oncology, as well as an LBA in Cell Biology and a University Diploma in Life Science and Health. He has been a Professor of Medical Oncology at the University of Angers since September 2012.
His research interests involve studies to determine the prognostic factors in breast cancer, as well as factors predictive of response to targeted therapies. He has also been the coordinator and principal investigator in numerous clinical studies of new therapeutic agents in breast pathology and glial tumours.
Dr Fatima Cardoso, MD
Dr Cardoso is the Director of the Breast Cancer Unit of the Champalimaud Cancer Center in Lisbon, Portugal. Dr Cardoso earned her medical degree at the University of Porto in Portugal and completed fellowships in the Translational Research Unit of the Jules Bordet Institute (IJB) in Brussels, Belgium, and the Department of Molecular and Cellular Oncology at MD Anderson Cancer Center in Houston, Texas. She then worked for 10 years as Assistant Professor at the Medical Oncology Clinic of the IJB where, besides her clinical work, she was active in the Translational Research Unit and was responsible for phase II-III trials in breast cancer. She is board certified in medical oncology and internal medicine.
Dr Cardoso’s research interests include biology of breast cancer, prognostic and predictive markers of response to systemic therapy, and new anticancer agents. She is actively involved in a number of phase I-III breast cancer clinical trials and served as the scientific director of the international research network TRANSBIG for 7 years. Dr Cardoso is actively involved in numerous professional organisations such as ESMO, ECCO, EORTC, ASCO, and AACR where she serves on several committees, including the ECCO Board of Directors and is the current EORTC Secretary General and vice-chair of the EORTC-Breast Cancer Group. She is the Breast Cancer Program Coordinator of the European School of Oncology and co-chair of the Advanced Breast Cancer International Consensus Guidelines Conference (ABC). Dr Cardoso is editor-in-chief of The Breast Journal, associate editor of the European Journal of Cancer, and has authored over 200 publications.
Dr Javier Cortes, MD, PhD
Dr Javier Cortes graduated in Medicine and Surgery from the Autonomous University of Madrid in 1996. He then went on to specialise at the University of Navarra’s Department of Medical Oncology where he would go on to work full time as Doctor in Medical Oncology from 2002. Since 2003, he has also worked in the Department of Medical Oncology at the Vall d’Hebron University Hospital, Barcelona, where he is Coordinator of the Teaching and Training Programme for Residents in Oncology and Senior Specialist in Breast Cancer with a particular interest in new drugs development. He is head of the Breast Cancer Unit and Melanoma Unit.
Dr Cortes is the author of numerous publications, with a strong focus on breast tumours and novel treatments. He actively participates in the development of several national and international clinical investigations, especially in relation to drugs directed against molecular targets and new chemotherapy agents.
Professor Michael Gnant, MD, FACS
Dr Michael Gnant graduated with a medical degree from the University of Vienna in 1988 before going on to specialise in surgery and surgical oncology. He enjoyed a two-year research period as Fellow and Visiting Scientist at the National Cancer Institute in Bethesda, USA, before returning to Europe to become a Professor of Experimental Surgical Oncology in 2004. In 2008, he was appointed Professor of Surgery at Vienna Medical University, where he presently serves as Director at the Department of Surgery, and co-directs the Comprehensive Cancer Center. Since 2005, he is President of the globally successful Austrian Breast and Colorectal Cancer Study Group.
Dr Gnant’s research interests include a variety of surgical oncology fields, in particular breast cancer and pancreatic cancer, endocrine intervention and bone targeted treatment. He has published more than 350 original papers in peer-reviewed journals, held numerous national and international talks, and served as principle investigator in many national and international clinical trials. He has received numerous awards for his work including the Grand Central European Award for Clinical Cancer Research, and the coveted Claudia von Schilling Prize. He is a frequent speaker at meetings such as ASCO, SABCS, ECCO, and EBCC, and serves as panelist of the St. Gallen Consensus since 2007.
Victoria Harmer, RN BSc (Hons) Dip (breast care) MBA AKC
Victoria Harmer is Team Leader and Clinical Nurse Specialist in breast care at Imperial College Healthcare Hospital NHS Trust. She qualified in nursing with an award for distinction in practice, and has 18 years’ oncology experience. Currently studying for her doctorate at King’s College, she is also a Trustee for Against Breast Cancer, a member of the Clinical Experts Reference Group for Breakthrough Breast Cancer, an Executive Committee member for Europa Donna UK, the nurse representative on the Association of British Surgery Education and Training Committee, a Steering Committee member of the RCN Cancer and Breast Care Forum and co-chairs the London Cancer Alliance breast nurses group.
Victoria has worked with Marks & Spencer on their swimwear design for the post-mastectomy body and has assisted scriptwriters on a variety of high profile TV programmes to ensure medical correctness when a character had breast cancer. She is proactive in raising breast cancer awareness and runs a monthly support group for breast cancer survivors. Her main passions are in the arena of surgery and sexuality. She recently came third in the ‘British Journal of Nursing Awards, 2013’ in the ‘Oncology and Haematology Nurse of the Year’ category, and is shortlisted for the ‘Cancer Nurse’ and ‘Nurse of the Year’ categories for the Nursing Times Awards 2013.
Diane Mackie, BSc
Diane is a Clinical Nurse Specialist in Secondary Breast Cancer at the Royal Marsden NHS Foundation Trust in London. Diane has over 25 years oncology nursing experience. In 1997 she became, along with a colleague as part of a job share, the first UK clinical nurse specialist for secondary breast cancer. This post at Charing Cross Hospital, London, was supported by the UK cancer charity, Macmillan Cancer Support, to improve the emotional and psychological needs of patients with secondary breast cancer.
Diane has been actively involved in the development of services for patients with secondary breast cancer locally and nationally, including contributing to NICE documents and membership of Breast Cancer Care’s Secondary Breast Cancer Taskforce. Her role supports dissemination of best practice, locally, nationally and internationally. Recent publications have included a specialist supportive care chapter written by Diane and her colleague Melissa Warren in the Handbook of Metastatic Breast Cancer by Prof Johnston and Dr Swanton and a poster presenting nurse-led research based on the needs of patients with metastatic breast cancer at last year’s San Antonio Breast Cancer Symposium.
Diane’s teaching and presenting commitments include work as an associate lecturer on the management of Metastatic Breast Cancer as part of the Breast Cancer Care module (BSc and MSc) at the School of Nursing and Rehabilitation at the Royal Marsden Hospital.
Dr Konstantinos Papazisis, MD PhD
Dr Konstantinos Papazisis is a Medical Doctor and Researcher in the field of Oncology. He obtained his Medical Degree from Ioannina University School of Medicine in November 1989 and Certification of Internal Medicine Specialisation in February 2001 after five years specialising as a clinical registrar in internal medicine, infectious diseases, haematology and oncology.
He is currently a Consultant Medical Oncologist at the Euromedica General Klinik in Thessaloniki. His clinical and research interests are extended to experimental and molecular oncology, signal transduction and the molecular targets in cancer therapeutics.
Professor Stephen Johnston, MA, PhD, FRCP
Stephen Johnston is Professor of Breast Cancer Medicine and Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London. He was the first Director of the UK’s National Institute for Health Research (NIHR) Biomedical Research Centre for Cancer at the Royal Marsden. He graduated in 1983 from Trinity College at The University of Cambridge, and in 1986 from The Medical School at The University of Newcastle upon Tyne. He trained in General Medicine at St Bartholomew's Hospital and Hammersmith Hospital in London, and subsequently in Medical Oncology at the Royal Marsden Hospital. He gained his PhD from the Institute of Cancer Research at the University of London, and took up his current position as Medical Oncologist on the Breast Unit at the Royal Marsden Hospital in 1997. He has a specialist interest in the treatment of metastatic breast cancer, and his major research interests lie in understanding mechanisms of endocrine resistance in breast cancer. He is actively involved in facilitating the interface between basic and applied research, and is chief investigator of several phase II / III trials of novel therapeutic approaches in advanced disease, including new endocrine therapies and targeted signal transduction inhibitors. He has published over 230 breast cancer related articles in peer-reviewed journals, and is a member of several scientific committees and advisory boards, a Faculty Member at the American Society for Clinical Oncology, the Deputy-Editor of the international journal ‘Breast Cancer Research’, and a former Trustee of the UK charity ‘Breast Cancer Campaign’ having also been Chairman of their Scientific Advisory Board.
Gill Donovan, BSc
Gill Donovan is a Breast Oncology Nurse Specialist and research fellow at Cardiff University. She has worked in the field of Oncology for over 30 years and is currently delivering education initiatives with a focus on training breast specialist nurses.
Gill has an interest in service redesign with a particular focus on utilising the qualifications and advanced skills of the multi-disciplinary team to deliver patient focused services. Gill has been running independent chemotherapy clinics for seven years using her prescribing qualification. She has presented at a number of conferences on the work of Non Medical Prescribers in the oncology setting with an emphasis on efficient and effective use of resources to improve patient care. She has also published several papers throughout her career on different aspects of her work.